Nephrostomy Devices Market Size, Share, Trends and Forecast 2030, by Types (Nephrostomy Tubes, Nephrostomy Catheters, Nephrostomy Balloons, Nephrostomy Stents) by Applications (Urinary Tract, Obstruction, Kidney Stones, Cancer)

Report ID :
1517

Publisher ID :
theinsightbridge

Published :
2023-05-23

Pages :
150

Purchase Option
$4500

Nephrostomy Devices Market Introduction 

Nephrostomy devices are medical devices used to create a percutaneous nephrostomy, which is a surgical procedure that involves the creation of a pathway between the skin and the kidney, allowing for the drainage of urine directly from the kidney to an external collection bag. This procedure is typically performed in cases where a blockage in the urinary tract prevents urine from flowing freely from the kidney to the bladder, resulting in a buildup of urine in the kidney.Nephrostomy devices include a range of products such as nephrostomy catheters, drainage bags, guidewires, and sheaths. These devices are typically made from materials such as silicone, polyurethane, or PVC, and come in a variety of sizes and configurations to accommodate different patient needs.Nephrostomy devices are commonly used in the treatment of conditions such as kidney stones, cancer, and congenital abnormalities, as well as in the management of patients undergoing renal transplantation. The use of these devices allows for the effective drainage of urine from the kidney, which can help to alleviate symptoms and prevent further complications.

Nephrostomy Devices Market  Size

The global nephrostomy devices market size was valued at USD 732.3 million in 2020, and it is expected to grow at a compound annual growth rate (CAGR) of 6.4% from 2021 to 2028. The increasing prevalence of kidney stones, kidney cancer, and other urological disorders, coupled with the growing elderly population, is driving the growth of the market.In addition, the rising adoption of minimally invasive procedures and technological advancements in nephrostomy devices are also contributing to the growth of the market. The demand for nephrostomy devices is expected to increase in the coming years, as healthcare providers continue to focus on improving patient outcomes and reducing healthcare costs.Geographically, North America is the largest market for nephrostomy devices, followed by Europe and Asia-Pacific. The market in North America is driven by the presence of a large patient population, well-established healthcare infrastructure, and favorable reimbursement policies. The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, due to the increasing prevalence of kidney stones and other urological disorders in the region.

Nephrostomy Devices Market  Share

The global nephrostomy devices market is highly competitive, with several key players operating in the market. Some of the major players in the market include:

  1. Boston Scientific Corporation
  2. Cook Medical Inc.
  3. Teleflex Incorporated
  4. C. R. Bard, Inc.
  5. Olympus Corporation
  6. Medline Industries, Inc.
  7. Argon Medical Devices, Inc.
  8. BD (Becton, Dickinson and Company)
  9. Merit Medical Systems, Inc.
  10. Amecath GmbH

These companies have a strong presence in the global nephrostomy devices market and account for a significant share of the market. They are constantly striving to develop new and innovative products to meet the evolving needs of the market. In addition, they are focusing on expanding their market presence through strategic partnerships, mergers and acquisitions, and collaborations with other companies. These companies are also investing in research and development activities to develop advanced nephrostomy devices that offer improved safety, efficacy, and patient comfort.

Nephrostomy Devices Market  Trends

Some of the key trends in the nephrostomy devices market include:

  1. Increasing adoption of minimally invasive procedures: Minimally invasive procedures have gained popularity in recent years due to their several advantages such as reduced hospital stay, lower risk of complications, and faster recovery. This trend is driving the demand for minimally invasive nephrostomy devices that offer improved safety and efficacy.
  2. Technological advancements in nephrostomy devices: The market is witnessing a rapid pace of technological advancements, with manufacturers developing innovative devices that offer improved safety, accuracy, and patient comfort. For instance, the development of hydrophilic coatings on catheters and guidewires reduces friction and trauma during the insertion process.
  3. Growing demand for home-based care: The rising trend of home-based care is driving the demand for nephrostomy devices that are easy to use and offer improved patient comfort. This trend is likely to increase in the coming years due to the growing elderly population and the increasing prevalence of chronic diseases.
  4. Increasing use of image-guided procedures: Image-guided procedures are becoming increasingly popular in the field of urology, as they offer improved accuracy and precision. This trend is driving the demand for image-guided nephrostomy devices that offer real-time visualization during the procedure.
  5. Growing focus on patient outcomes and value-based care: Healthcare providers are increasingly focusing on improving patient outcomes and reducing healthcare costs. This trend is driving the demand for nephrostomy devices that offer improved safety and efficacy, while also reducing hospital stay and overall healthcare costs.

Nephrostomy Devices Market Driving factors

The global nephrostomy devices market is primarily driven by the following factors:

  1. Increasing prevalence of kidney stones and other urological disorders: The rising incidence of kidney stones, kidney cancer, and other urological disorders is driving the demand for nephrostomy devices. 
  2. Growing elderly population: The global population is aging rapidly, which is leading to a growing prevalence of chronic diseases such as kidney stones and kidney cancer. The elderly population is more susceptible to these diseases, which is driving the demand for nephrostomy devices.
  3. Technological advancements in nephrostomy devices: The market is witnessing a rapid pace of technological advancements, with manufacturers developing innovative devices that offer improved safety, accuracy, and patient comfort. This is driving the demand for advanced nephrostomy devices that offer improved outcomes.
  4. Increasing adoption of minimally invasive procedures: Minimally invasive procedures have gained popularity in recent years due to their several advantages such as reduced hospital stay, lower risk of complications, and faster recovery. This trend is driving the demand for minimally invasive nephrostomy devices that offer improved safety and efficacy.
  5. Favorable reimbursement policies: Favorable reimbursement policies for nephrostomy procedures are driving the demand for nephrostomy devices. The availability of reimbursement for these procedures is encouraging more patients to undergo nephrostomy procedures, which is driving the demand for nephrostomy devices.

Overall, the growing prevalence of kidney stones and other urological disorders, coupled with the increasing elderly population and the rapid pace of technological advancements in nephrostomy devices, is driving the growth of the global nephrostomy devices market.

Nephrostomy Devices Market  Reginal Analysis

The global nephrostomy devices market can be analyzed regionally as follows:

  1. North America: North America is the largest market for nephrostomy devices, owing to the high prevalence of kidney stones and other urological disorders in the region. The availability of advanced healthcare infrastructure and favorable reimbursement policies are also driving the growth of the market in North America.
  2. Europe: Europe is another major market for nephrostomy devices, due to the growing elderly population and the increasing incidence of chronic diseases in the region. The favorable reimbursement policies and the increasing adoption of minimally invasive procedures are also driving the growth of the market in Europe.
  3. Asia-Pacific: The Asia-Pacific region is expected to witness significant growth in the nephrostomy devices market in the coming years, due to the increasing incidence of kidney stones and kidney cancer in the region. The growing healthcare infrastructure and the increasing focus on healthcare modernization are also driving the growth of the market in Asia-Pacific.
  4. Middle East and Africa: The Middle East and Africa is a growing market for nephrostomy devices, due to the increasing prevalence of urological disorders in the region. The growing healthcare infrastructure and the increasing adoption of advanced medical technologies are also driving the growth of the market in this region.
  5. Latin America: Latin America is another emerging market for nephrostomy devices, due to the growing prevalence of kidney stones and other urological disorders in the region. The increasing healthcare expenditure and the growing demand for advanced medical technologies are also driving the growth of the market in Latin America.

Overall, the nephrostomy devices market is expected to witness significant growth globally, driven by the increasing prevalence of urological disorders, the growing elderly population, and the rapid pace of technological advancements in the field.

Nephrostomy Devices Market  Forecasts 2030

The global nephrostomy devices market is expected to witness significant growth during the forecast period of 2021-2030.The market is projected to grow at a CAGR of approximately 8.5% during the forecast period, and reach a market value of approximately USD 1.2 billion by 2030.The increasing prevalence of kidney stones and other urological disorders, coupled with the growing elderly population and the rapid pace of technological advancements in nephrostomy devices, are expected to drive the growth of the market during the forecast period. The increasing adoption of minimally invasive procedures and the favorable reimbursement policies for nephrostomy procedures are also expected to contribute to the growth of the market.In terms of product type, the market is expected to be dominated by the percutaneous nephrostomy segment, due to the advantages offered by this type of device such as improved accuracy, reduced risk of complications, and faster recovery times. In terms of end-user, the hospitals segment is expected to account for the largest share of the market, owing to the high patient footfall and the availability of advanced healthcare infrastructure in hospitals.Geographically, North America is expected to remain the largest market for nephrostomy devices, owing to the high prevalence of urological disorders in the region and the availability of advanced healthcare infrastructure. However, the Asia-Pacific region is expected to witness significant growth during the forecast period, driven by the increasing incidence of kidney stones and kidney cancer in the region, and the growing healthcare infrastructure.Overall, the nephrostomy devices market is expected to witness significant growth during the forecast period, driven by the increasing prevalence of urological disorders and the rapid pace of technological advancements in the field.

Nephrostomy Devices Market Key Industry Players

Some of the key players operating in the global nephrostomy devices market include:

  1. Boston Scientific Corporation
  2. C. R. Bard, Inc. (Becton, Dickinson and Company)
  3. Cook Medical LLC
  4. Medtronic plc
  5. Olympus Corporation
  6. Cardinal Health, Inc.
  7. Teleflex Incorporated
  8. Argon Medical Devices, Inc.
  9. UreSil, LLC
  10. Amecath GmbH

These companies are focusing on developing new and innovative products to enhance their market share and meet the growing demand for nephrostomy devices. They are also engaging in strategic collaborations and partnerships to expand their market presence and increase their product offerings. Additionally, these companies are investing heavily in research and development activities to bring about technological advancements in the field of nephrostomy devices, in order to improve patient outcomes and enhance the efficacy of these devices.

n/a

n/a

n/a

Our Clients